Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment

Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment 02-Jun-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is...

Related Keywords

Zurich ,Züsz ,Switzerland ,United States ,Netherlands ,Swiss ,Hans Herklots ,Michael Grau ,Kuros Biosciences ,Regeneron Pharmaceuticals ,News Service ,Swiss Exchange ,Checkmate Pharmaceuticals ,Chief Executive Officer ,Sci Advisors ,Bag ,Key ,Iscellaneous ,Euros ,Iosciences ,Completion ,Checkmate ,Pharmaceuticals ,Regeneron ,Et Cest ,Release ,Art ,Dr ,The ,